Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies

By  

Current Cancer Drug Targets, Vol. 5, Iss. 8, 2005-12 ,pp. : 573-578

Bentham Science Publishers

Access to resources Recommend Favorite

Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study

By LoRusso Patricia   Krishnamurthi Smitha   Youssoufian Hagop   Hall Nancy   Fox Floyd   Dontabhaktuni Aruna   Grebennik Dmitri   Remick Scot  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 303-311

Springer Publishing Company

Access to resources Recommend Favorite

Co-Expression of Vascular Endothelial Growth Factor and Interleukin-1 Receptor Antagonist Improves Human Islet Survival and Function

By Narang Ajit   Sabek Omaima   Gaber Ahmed   Mahato Ram  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 1970-1982

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis and Evaluation of Vascular Endothelial Growth Factor Receptor-2 Inhibitory Activity of 6,7-Dimethoxycinnoline Derivatives

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 10, 2013-01 ,pp. : 984-988

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors targeting vascular endothelial growth factor receptor kinases and cyclin-dependent kinases

By  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 337-341

Informa Healthcare

Access to resources Recommend Favorite